Article
Novel mutant human fibronectin FIII9-10 domain pair with increased conformational stability and biological activity.
Protein engineering - 1 Dec 2002
van der Walle Christopher F, Altroff Harri, Mardon Helen J
Abstract excerpt
The ninth and tenth type III domains (FIII9-10) in the central cell binding domain of human fibronectin contain integrin receptor binding sites, including RGD in FIII10 and a synergy site, PHSRN, in FIII9. The specific amino acids that contribute to cell binding have been identified by the use of wild-type and mutant fragments of human fibronectin containing the FIII9-10 domain pair. At high concentrations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
